» Articles » PMID: 10378690

Mysterious Liaisons: the Relationship Between C-Myc and the Cell Cycle

Overview
Journal Oncogene
Date 1999 Jun 23
PMID 10378690
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the Cdk inhibitor p27KIP1. Cyclin D/Cdk4/6 complexes have also been implicated as targets of c-Myc activity. However, in spite of considerable effort, the mechanisms by which c-Myc interacts with the intrinsic cyclin/Cdk cell cycle machinery remain undefined.

Citing Articles

Non-canonical pathway for Rb inactivation and external signaling coordinate cell-cycle entry without CDK4/6 activity.

Zhang M, Kim S, Yang H Nat Commun. 2023; 14(1):7847.

PMID: 38030655 PMC: 10687137. DOI: 10.1038/s41467-023-43716-y.


P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.

Sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S J Transl Med. 2023; 21(1):132.

PMID: 36803784 PMC: 9940387. DOI: 10.1186/s12967-023-03985-z.


S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer.

Mo H, Liu X, Xue Y, Chen H, Guo S, Li Z Mol Cancer. 2022; 21(1):171.

PMID: 36042494 PMC: 9426012. DOI: 10.1186/s12943-022-01642-5.


Allostery, and how to define and measure signal transduction.

Nussinov R, Tsai C, Jang H Biophys Chem. 2022; 283:106766.

PMID: 35121384 PMC: 8898294. DOI: 10.1016/j.bpc.2022.106766.


Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis.

Malengier-Devlies B, Metzemaekers M, Wouters C, Proost P, Matthys P Front Immunol. 2021; 12:766620.

PMID: 34966386 PMC: 8710701. DOI: 10.3389/fimmu.2021.766620.